BPC-157 peptide in vascular and microcirculation research Due to its signaling profile, BPC-157 peptide is often included in experimental models examining vascular organization and microcirculation mechanisms
It was first reported by Sawyer, Hruby, Hadley and colleagues in the Proceedings of the National Academy of Sciences in 1980, and it departs from native human alpha-MSH at only two of thirteen positions: norleucine replaces the oxidation-prone methionine at position 4, and the phenylalanine at position 7 is inverted to its D-enantiomer
Its clinical application is constrained by inadequate water solubility, diminished bioavailability, and fast metabolism
Use a fresh alcohol pad to wipe the vial stopper before every draw
A.BevanS
This fact is relevant as transgenic mice overexpressing IGFBP-2 were resistant to developing obesity when fed with high fat diet [174], suggesting that this molecule could have a direct effect on preadipocyte differentiation